Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin for Alcohol Relapse Prevention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Meets criteria for alcohol use disorder based on DSM-5 criteria~2. Meets criteria for history of alcohol withdrawal based on DSM-5 criteria~3. Able to maintain abstinence for a minimum of 3 days prior to randomization as verified by self report, urine ETG, and breathalyzer.~Exclusion Criteria:~1. Significant psychiatric or medical illness~2. No other substance abuse~3. Taking other medications known to treat alcohol use disorder~4. Unstable living arrangements~5. Significant legal problems pending

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Gabapentin (Type: EXPERIMENTAL): Gabapentin up to 1200 mg per day in 3 divided doses
- placebo (Type: PLACEBO_COMPARATOR): matching placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).